|
|
Article: Primary biliary cirrhosis research at Mount Sinai advances due to trust, trials.
- Article from:
- Immunotherapy Weekly
- Article date:
- January 14, 2004
CopyrightCOPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2004 JAN 14 - (NewsRx.com & NewsRx.net) -- Primary biliary cirrhosis research at Mount Sinai advances due to trust money, clinical trials.
According to published research from the United States, "individuals afflicted with primary biliary cirrhosis (PBC) first undergo chronic, nonsuppurative destruction of their intrahepatic bile ducts, eventually leading to cirrhosis.
"Over nearly 50 years, many faculty members at the Mount Sinai School of Medicine, including Hans Popper, MD, and Fenton Schaffner, MD, have made important contributions to our understanding of the natural history and histopathologic evolution of PBC. Today, many patients with PBC ...